The secret is out: Investing in psychedelics may be the next explosive trend for investors looking to enter a new industry with massive social impact. Despite many media outlets comparing psychedelic drugs to cannabis, the reality is that psychedelic medicine is much more likely to follow the “traditional biotech path.”
That path includes high barriers to entry, complicated legislative hurdles, and the need for highly qualified professionals. Entrepreneurs will need to focus on hard science that provides real solutions, instead of simple creative thinking with a salesperson flair.
